Changes of plasma biomolecules in patients with acute cerebral infarction before and after treatment
QIU LI-Jun,GU Qing,WANG Wei-le,SHEN Li-song
DOI: https://doi.org/10.3969/j.issn.1674-8115.2007.03.025
2007-01-01
Abstract:Objective To study the changes of plasma biomolecules in patients with acute cerebral infarction(ACI) and the potential influences from lumbrukinase and aspirin(ASA). Methods Seventy patients with ACI were randomly divided into three groups according to the ways of administration: lumbrukinase group(n=26),ASA group(n=24)and lumbrukinase + ASA group(n=20).Plasma levels of P-selectin,D-dimer(D-D),tissue plasminogen activator(t-PA),plasminogen activator inhibitor-1(PAI-1),plasmin-antiplasmin complex(PAP),thrombin-antithrombin complex(TAT),homocysteine(Hcy) and thrombin-activatable fibrinolysis inhibitor(TAFI) were measured in these patients with ACI and normal individuals(n=20) by ELISA method.Changes of these parameters were detected before and after the treatment,and the diagnostic efficiencies for ACI were compared by receiver characteristic curve(ROC).Results Before the treatment,all the parameters in patients with ACI were significantly higher than those in the healthy controls(P<0.05,P<0.01).The plasma level of D-D was positively related to those of t-PA,PAI-1,P-selectin,TAT and PAP.After the threatment,the plasma levels of biomolecules in the ASA group did not change significantly(P>0.05).However,there were significant changes of PAP in the lumbrukinase group(P<0.05) and PAP and PAI-1 in the lumbrukinase + ASA group(P<0.05).D-D,TAFI: Ag and TAFI:a were more sensitive and specific than the other plasma biomolecules.Conclusion Either t-PA,PAI-1,P-selectin,TAT,PAP,D-D,Hcy,TAFI: a and TAFI: Ag may serve as diagnostic tool for ACI,and D-D,TAFI: a and TAFI: Ag are better in sensitivity and specificity.Treatment with lumbrukinase + ASA may lead to more significant changes in plasma biomolecules.